The global prebiotic-fibre segment is surging as consumers look beyond basic gut health toward holistic benefits spanning metabolic, cardiovascular and even cognitive wellness.
In Europe alone, the prebiotic market was valued at $3.71 billion in 2024, is projected to reach $4.18 billion in 2025 and could climb to $10.77 billion by 2033 (at CAGR of approximately 12.6%).
Across the Atlantic, the US prebiotic-fibre segment stood at $1.45 billion in 2024, with forecasts predicting a rise to $2.35 billion by 2030 (CAGR ≈ 8.4%).
This double-digit growth underscores an urgent need for science-backed formulations that deliver proven multi-benefit functionality.1